Morgan Stanley Maintains Underweight on Lazard, Lowers Price Target to $61

Benzinga · 2d ago
Morgan Stanley analyst Ryan Kenny maintains Lazard (NYSE:LAZ) with a Underweight and lowers the price target from $62 to $61.